Financials
- Market Capitalization 498.74 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato
-8 738.88
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2909 | VSTM Verastem, Inc. - Common Stock | 5.77 USD | +0.70% | +6.85% | +36.08% | +11.61% | 507.03 M USD | ||
| 2921 | XOMA XOMA Royalty Corporation - Common Stock | 40.17 USD | 0.00% | -8.39% | -3.99% | +13.96% | 503.77 M USD | ||
| 2936 | NVCT Nuvectis Pharma, Inc. - Common Stock | 18.60 USD | -5.05% | -1.38% | +44.30% | +131.63% | 493.37 M USD | ||
| 2941 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.61 USD | +0.62% | -9.55% | -8.52% | -22.60% | 486.32 M USD |